Abstract:Background Temozolomide, an alkylating agent, is a promising chemotherapeutic agent for treating glioblastoma. Although chemotherapy with temozolomide may restrain tumor growth for some months, invariable tumor recurrence suggests that cancer stem cells maintaining these tumors persist. Previous research has shown that temozolomide can inhibit the proliferation of human glioblastoma stem cells (GSCs); however, no research has focused on the invasion of GSCs, which is an important factor for glioblastoma recurrence. Accumulating evidence indicates that microRNA (miR)-125b over-expression in GSCs may increase their invasiveness. Objective Our objective was to identify the effects and mechanism of action of an miR-125b inhibitor combined with temozolomide in the invasive pathogenesis of GSCs. Methods We modified the levels of miR-125b expression in primary GSCs in order to observe the effect on sensitivity to temozolomide on invasion, and we further analyzed the differences in mechanism between miR-125b treatment alone and treatment with miR-125b plus temozolomide using the Cancer PathwayFinder PCR Array. Results Our results demonstrated that either an miR-125b inhibitor or temozolomide could modestly inhibit the invasiveness of GSCs. Furthermore, GSCs that were pre-transfected with an miR-125b inhibitor, then treated with temozolomide, showed significantly decreased invasiveness when compared with GSCs treated with an miR-125b inhibitor or temozolomide alone. Further research into the underlying mechanism demonstrated that the miR-125b inhibitor enhanced the invasion-prevention activity of temozolomide in GSCs through targeting PIAS3 (protein inhibitor of activated STAT [signal transducer and activator of transcription]), which contributed to reduced STAT3 transcriptional activity and subsequent decreased expression of matrix metalloproteinase (MMP)-2 and -9. Conclusions miR-125b could play a role in the development of temozolomide resistance in GSCs. Inhibition of miR-125b expression may enhance sensitivity of GSCs to temozolomide by targeting PIAS3 on cell invasion.

MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways

MiR-125b Promotes Cell Migration and Invasion by Targeting PPP1CA-Rb Signal Pathways in Gastric Cancer, Resulting in a Poor Prognosis

Mir-1258 Attenuates Tumorigenesis Through Targeting E2F1 to Inhibit PCNA and MMP2 Transcription in Glioblastoma.

Mir-125B Inhibits Connexin43 and Promotes Glioma Growth

Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

MicroRNA-125b Promotes Apoptosis by Regulating the Expression of Mcl-1, Bcl-w and IL-6R

Mir-125b Promotes Cell Proliferation by Directly Targeting Lin28 in Glioblastoma Stem Cells with Low Expression Levels of Mir-125b

MicroRNA-125b inhibitor sensitizes human primary glioblastoma cells to chemotherapeutic drug temozolomide on invasion

MiR125a-5p acting as a novel Gab2 suppressor inhibits invasion of glioma.

Downregulation of Mir-124 Promotes the Growth and Invasiveness of Glioblastoma Cells Involving Upregulation of PPP1R13L.

Microrna-138 Modulates Glioma Cell Growth, Apoptosis And Invasion Through The Suppression Of The Akt/Mtor Signalling Pathway By Targeting Creb1

MicroRNA-125b-2 Confers Human Glioblastoma Stem Cells Resistance to Temozolomide Through the Mitochondrial Pathway of Apoptosis.

Expression of Mir-125B in the New,highly Invasive Glioma Stem Cell and Progenitor Cell Line SU3

MicroRNA-125b expression in gastric adenocarcinoma and its effect on the proliferation of gastric cancer cells.

MicroRNA-125b may function as an oncogene in lung cancer cells.

Functional Differences of Mir-125B on the Invasion of Primary Glioblastoma CD133-Negative Cells and CD133-Positive Cells

Mir-125B Regulates the Proliferation of Glioblastoma Stem Cells by Targeting E2F2.

MicroRNA-16-5p Inhibits the Proliferation and Invasion of Glioma Cells by the Activation of P53/bax Signal Pathway

miR‐124‐3p inhibits the viability and motility of glioblastoma multiforme by targeting RhoG

miR-125b Inhibitor May Enhance the Invasion-Prevention Activity of Temozolomide in Glioblastoma Stem Cells by Targeting PIAS3

MiRNA-125a-5p Inhibits Glioblastoma Cell Proliferation and Promotes Cell Differentiation by Targeting TAZ.